All Chemotherapy Drugs

	A	B	C	D	E	F	G
1			from https://callaix.com/medicines
2
3	Medicine	Trade Name	Category	Sub-category 1	Sub-category 2	Year of First FDA approval	Types of Cancer
4	Abemaciclib	Verzenio	Kinase Inhibitor	CDK (Cyclin-Dependent Kinase) Inhibitor		2017	breast cancer
5	Abiraterone	Zytiga	Anti-Androgen	CYP17A1 inhibitor		2011	prostate cancer
6	Acalabrutinib	Calquence	Kinase Inhibitor	BTK inhibitor		2017	mantle cell carcinoma, chronic lymphocytic leukemia
7	Actinomycin-D	Act-D, Cosmegen, Dactinomycin	Antibiotic			1964	many sarcomas and some carcinomas
8	Adagrasib	Krazati	Kinase Inhibitor			2022	non-small cell lung cancer
9	Ado-trastuzumab	Kadcyla	Antibody-drug conjugate	HER2 inhibitor		2019	breast cancer
10	Afatinib	Gilotrif	Kinase Inhibitor			2013	non-small cell lung cancer
11	Aldesleukin	Proleukin	Immunostimulant			1992	melanoma, renal cell carcinoma
12	Alectinib	Alecensa	Kinase Inhibitor			2015	non-small cell lung cancer
13	Alemtuzumab	Campath	Monoclonal Antibody			2014	B-cell chronic lymphocytic leukemia
14	Alpelisib	Piqray	PI3K Inhibitor			2019	breast cancer
15	Alitretinoin	Panretin, Toctino	Retinoid			1999	Karposi's sarcoma
16	Altretamine	Hexalen	Alkylating agent			1990	ovarian cancer
17	Amivantamab-vmjw	Rybrevant	Monoclonal Antibody			2021	non-small cell lung cancer
18	Aminoglutethimide	Cytadren	Aromatase inhibitor			1980	breast cancer, prostate cancer
19	Anastrozole	Arimidex	Aromatase inhibitor			1995	breast cancer
20	Apalutamide	Erleada	Anti-Androgen			2019	prostate cancer
21	Arsenic Trioxide		Other			2000	leukemia
22	Asciminib	Scemblix	Kinase Inhibitor			2021	leukemia
23	Asparaginase, L-asparaginase	Elspar, Kidrolase	Enzyme			2011	acute lymphocytic leukemia
24	Atezolizumab	Tecentriq	Monoclonal Antibody	checkpoint inhibitor	Anti-PD-1	2016	small cell lung cancer, urothelial carcinoma, breast cancer, non-small cell lung cancer
25	Avapritinib	Ayvakit	Kinase Inhibitor			2020	gastrointestinal stromal tumor
26	Avelumab	Bavencio	Monoclonal Antibody	checkpoint inhibitor	Anti-PD-1	2017	merkel cell carcinoma, renal cell carcinoma, urothelial carcinoma
27	Axicabtagene	Yescarta	CAR T-Cell therapy			2017	lymphoma
28	Axitinib	Inlyta	Kinase Inhibitor	VEGF/VEGFR inhibitor		2012	renal cell carcinoma
29	Azacitidine	Vidaza	Antimetabolite			2004	myelodysplastic syndromes, leukemia
30	Belantamab mafodotin-blmf	Blenrep	Monoclonal Antibody			2020	multiple myeloma
31	Belinostat	Beleodaq	HDAC Inhibitor			2014	lymphoma
32	Bendamustine	Treanda	Alkylating Agent	Mustard		2008	B-cell non-Hodgkin lymphoma, Chronic lymphocytic leukemia
33	Bevacizumab	Avastin	Monoclonal Antibody	Angiogenesis inhibitor	VEGF/VEGFR inhibitor	2004	colorectal cancer, renal cell carcinoma, cervical cancer, glioblastoma, nonsquamous non-small cell lung cancer, ovarian epithelial cancer
34	Bexarotene	Targretin	Retinoid			1999	Skin problems caused by cutaneous T-cell lymphoma
35	Bicalutamide	Casodex	Anti-Androgen			1995	prostate cancer
36	Binimetinib	Mektovi	Kinase Inhibitor			2018	melanoma
37	Bleomycin	Blenoxane	Antibiotic			1979	lymphoma, melanoma, sarcoma, ovarian cancer, testicular cancer
38	Blinatumomab	Blincyto	Monoclonal Antibody			2014	B-cell acute lymphoblastic leukemia
39	Bortezomib	Velcade	Proteasome inhibitor			2003	mantle cell lymphoma, multiple myeloma
40	Bosutinib	Bosulif	Kinase Inhibitor	Bcr-Abl inhibitor		2012	chronic myelogenous leukemia
41	Brentuximab vedotin	Adcetris	Antibody-drug conjugate			2011	peripheral T-cell lymphoma, cutaneous T-cell lymphoma, cutaneous anaplastic large cell lymphoma, Hodgkin's Disease, anaplastic large cell lymphoma
42	Brigatinib	Alunbrig	Kinase Inhibitor	ALK inhibitor		2017	non-small cell lung cancer
43	Busulfan	Myleran	Alkylating Agent	Alkyl sulfonate		1999	chronic myelogenous leukemia
44	Cabazitaxel	Jevtana	Mitotic Inhibitor	Taxane		2010	prostate cancer
45	Cabozantinib	Cabometyx	Kinase Inhibitor	VEGF/VEGFR inhibitor		2012	renal cell carcinoma, hepatocellular carcinoma, medullary thyroid cancer
46	Calaspargase pegol-mknl	Asparlas	Enzyme			2018	acute lymphoblastic leukemia
47	Camptothecin	Camptosar	Topoisomerase inhibitor			2012	colon cancer, rectal cancer
48	Capecitabine	Xeloda	Antimetabolite	Prodrug of Fluorouracil		2005	Breast cancer, colorectal cancer
49	Capivasertib	Truqap	Monoclonal Antibody			2023	breast cancer
50	Capmatinib	Tabrecta	Kinase Inhibitor			2020	non small-cell lung cancer
51	Carboplatin	Paraplatin	Alkylating Agent	Platinum compound		1989	ovarian cancer and other types
52	Carfilzomib	Kyprolis	Proteasome inhibitor			2012	multiple myeloma
53	Carmustine	BiCNU	Alkylating Agent	Nitrosurea		1996	brain tumors, Hodgkin's Disease, multiple myeloma, Non-Hodgkin's lymphoma
54	Cemiplimab-rwlc	Libtayo	Monoclonal Antibody	checkpoint inhibitor	Anti-PD-1	2018	cutaneous squamous cell carcinoma
55	Ceritinib	Zykadia	Kinase Inhibitor	ALK inhibitor		2014	non-small cell lung cancer
56	Cetuximab	Erbitux	Monoclonal Antibody	EGFR inhibitor		2009	colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer
57	Clofarabine	Clolar	antimetabolite			2014	acute lymphoblastic leukemia
58	Chlorambucil	Leukeran	Alkylating Agent	Mustard		1957	Chronic lymphocytic leukemia, Hodgkin's disease. Non-Hodgkin's lymphoma, ovarian cancer, testicular cancer, and others
59	Cisplatin	Platinol	Alkylating Agent	Platinum compound		1978	bladder cancer, testicular cancer, ovarian cancer, esophageal, lung, breast, cervical, stomach and prostate cancers
60	Cladribine	Litak and Movectro	Antimetabolite	Adenosine deaminase inhibitor		1993	hairy cell leukemia, acute myeloid leukemia, chronic lymphocytic leukemia, lymphoma
61	Cobimetinib	Cotellic	MEK Inhibitor			2015	melanoma
62	Copanlisib	Aliqopa	PI3K Inhibitor			2017	follicular lymphoma
63	Crizotinib	Xalkori	Kinase Inhibitor			2011	non-small cell lung cancer
64	Cyclophosphamide	Endoxan, Cytoxan, Neosar	Alkylating Agent	Mustard		1959	Retinoblastoma, Chronic myelogenous leukemia, Hodgkin's disease, Multiple myeloma, Mycosis fungoides, Neuroblastoma, Non-Hodgkin lymphoma, Acute lymphoblastic leukemia, Acute monocytic leukemia, Acute myeloid leukemia, Breast cancer, Chronic granulocytic leukemia. Chronic lymphocytic leukemia
65	Cytarabine	Cytosar-U, Arabinosylcytosine	Antimetabolite			1969	Acute lymphoblastic leukemia (ALL), Acute myeloid leukemia (AML), Chronic myelogenous leukemia (CML), promyelocytic leukemia
66	Dabrafenib	Taflinar	Kinase Inhibitor	BRAF inhibitor		2013	anaplastic thyroid cancer, melanoma, non-small cell lung cancer
67	Dacarbazine	DTIC, DTIC-Dome	Alkylating Agent			1975	melanoma, Hodgkin's Disease, sarcomas, neuroblastoma, and thyroid cancer
68	Dacomitinib	Vizimpro	Kinase Inhibitor	EGFR inhibitor	HER2 inhibitor	2018	non-small cell lung cancer
69	Daratumumab	Darzalex	Monoclonal Antibody			2015	multiple myeloma
70	Darolutamide	Nubeqa	Anti-Androgen			2019	prostate cancer
71	Dasatinib	Sprycel	Kinase Inhibitor	Bcr-Abl inhibitor		2006	acute myeloid leukemia, chronic lymphocytic leukemia
72	Daunorubicin	DaunoXome, Cerubidine	Anthracycline	Antibiotic		1979	acute lymphoblastic leukemia, acute myelogenous leukemia, acute promyelocytic leukemia
73	Decitabine	Dacogen	Antimetabolite	Cytosine Analog		2006	Myelodysplastic syndromes
74	Degarelix	Firmagon	Anti-Androgen			2008	prostate cancer
75	Denileukin diftitox	Ontak	Antibody-drug conjugate		no longer on market	1999	leukemia and lymphoma
76	Dinutuximab	Unituxin	Monoclonal Antibody			2015	neuroblastoma
77	Docetaxel	Taxotere	Mitotic Inhibitor	taxane		1996	breast, prostate, stomach cancer, non-small cell lung cancer, head and neck cancer
78	Dostarlimab-gxly	Jemperli	Monoclonal Antibody			2021	endometrial cancer
79	Doxorubicin	Adriamycin	Anthracycline	Antibiotic		1974	lymphoblastic and myeloid leukemia, breast cancer, stomach cancer, Hodgkin's lymphoma, neuroblastoma, non-Hodgkin lymphoma, ovarian cancer, small cell lung cancer, soft tissue and bone sarcomas, thyroid cancer, bladder cancer, Wilms tumor.
80	Durvalumab	Imfinzi	Monoclonal Antibody	checkpoint inhibitor	Anti-PD-1	2017	non-small cell lung cancer, urothelial carcinoma
81	Duvelisib	Copiktra	PI3K Inhibitor			2018	follicular lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma
82	Elacestrant	Orserdu	Antiestrogen			2023	breast cancer
83	Elotuzumab	Emplicit	Monoclonal Antibody			2015	multiple myeloma
84	Elranatamab-bcmm	Elrexfio	Monoclonal Antibody			2023	multiple myeloma
85	Enasidenib	Idhifa	IDH2 inhibitor			2017	acute myeloid leukemia
86	Encorafenib	Braftovi	Kinase Inhibitor	BRAF inhibitor		2018	melanoma
87	Enfortumab vedotin-ejfv	Padcev	Antibody-drug conjugate			2019	urothelial cancer
88	Entrectinib	Rozlytrek	Kinase Inhibitor			2019	non-small cell lung cancer
89	Enzalutamide	Xtandi	Anti-androgen			2012	prostate cancer
90	Epirubicin	Ellence	Anthracycline	Antibiotic		1999	breast cancer
91	Epcoritamab-bysp	Epkinly	Monoclonal Antibody			2023	large B-cell lymphoma
92	Erdafitinib	Balversa	Kinase Inhibitor	FGFR inhibitor		2019	urothelial carcinoma and bladder cancer
93	Eribulin	Halaven	Mitotic Inhibitor			2010	breast cancer
94	Erlotinib	Tarceva	Kinase Inhibitor	EGFR inhibitor		2004	pancreatic cancer, non-smell lung cancer
95	Estramustine	Emcyt, Estracit	Hormone Suppressant	Mustard		1981	prostate cancer
96	Etoposide	Eposin, Vepesid	Topoisomerase inhibitor	plant alkaloid		1983	small cell lung cancer, testicular cancer
97	Everolimus	Afinitor, Zortress	mTOR inhibitor			2010	kidney, breast, pancreatic, gastrointestinal, lung cancer, sarcomas, lymphomas
98	Exemestane	Aromasin	Aromatase Inhibitor			1999	breast cancer
99	Fam-trastuzumab deruxtecan-nxki	Enhertu	Antibody-drug conjugate			2019	breast cancer
100	Fluorouracil (5-FU)	Adrucil	Antimetabolite			1962	bladder, anal, breast, gastrointestinal, thymic, cervical, head and neck, and colorectal cancer